Author:
Seguin F,Carvalho M A,Bastos D C,Agostini M,Zecchin K G,Alvarez-Flores M P,Chudzinski-Tavassi A M,Coletta R D,Graner E
Publisher
Springer Science and Business Media LLC
Reference59 articles.
1. Alli PM, Pinn ML, Jaffee EM, McFadden JM, Kuhajda FP (2005) Fatty acid synthase inhibitors are chemopreventive for mammary cancer in neu-N transgenic mice. Oncogene 24: 39–46
2. Almeida JP, Coletta RD, Silva SD, Agostini M, Vargas PA, Bozzo L, Graner E (2005) Proliferation of fibroblasts cultured from normal gingiva and hereditary gingival fibromatosis is dependent on fatty acid synthase activity. J Periodontol 76: 272–278
3. Alò PL, Visca P, Framarino ML, Botti C, Monaco S, Sebastiani V, Serpieri DE, Di Tondo U (2000) Immunohistochemical study of fatty acid synthase in ovarian neoplasms. Oncol Rep 7: 1383–1388
4. Bates DO, Cui TG, Doughty JM, Winkler M, Sugiono M, Shields JD, Peat D, Gillatt D, Harper SJ (2002) VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma. Cancer Res 62: 4123–4131
5. Browne CD, Hindmarsh EJ, Smith JW (2006) Inhibition of endothelial cell proliferation and angiogenesis by orlistat, a fatty acid synthase inhibitor. FASEB J 20: 2027–2035
Cited by
127 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献